Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion evidence source_evidence_literature NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion SIO_000772 10688044 NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion wasDerivedFrom befree-20150227 NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_assertion wasGeneratedBy ECO_0000203 NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP302230.RAd_MVprFPKY1IQMVu9F5x9INi7-CXhhRpkBqXzgyS6WA130_provenance.